Results 21 to 30 of about 377,973 (217)
Catalysis Communications, 2022 Cu-ZrO2 is demonstrated to be a highly effective catalyst for the transfer hydrogenation of methyl levulinate to γ-valerolactone, using methanol as the hydrogen donor.
Mark Douthwaite +6 more
doaj +1 more source
Leucine‐rich glioma inactivated 1 (LGI1) is a ganglioside‐binding protein
FEBS Letters, EarlyView.Neuronal hyperexcitability associated with a decrease/absence of the extracellular protein LGI1 has been suggested to be primarily due to the downregulation of Kv1 channel expression. The molecular mechanisms underlying this decrease have not yet been elucidated.
Kévin Debreux +7 more
wiley +1 more source
A context‐dependent modulatory role for eIF6 in acquired resistance to vemurafenib in melanoma
FEBS Letters, EarlyView.Acquired resistance to vemurafenib upregulates the translation factor eIF6 in melanoma cells. Silencing eIF6 in resistant cells reduces proliferation and partially restores drug sensitivity, whereas its overexpression increases sensitivity across melanoma lines regardless of BRAF status, via modulation of mTOR, S6K, and MAPK signaling.
George Kyriakopoulos +9 more
wiley +1 more source
The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers
Molecular Oncology, EarlyView.The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce +11 more
wiley +1 more source
Molecular Oncology, EarlyView.Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla +9 more
wiley +1 more source
Planning for Offshore Integrated Energy Islands with Electricity-Carbon-Hydrogen-Methanol Synergy
南方能源建设[Objective] As nearshore wind resources approach saturation, the development of deep-sea wind power is facing a critical opportunity of scalable growth.
Chuanbo XU +4 more
doaj +1 more source
Research on carbon emission accounting thresholds for green methanol based on forward-looking policy orientation [PDF]
E3S Web of ConferencesIn the global energy transition, green methanol plays a key role due to its low-carbon and environmentally friendly properties. This study systematically analyzes the carbon footprint of green methanol, identifies key influencing factors, and calculates ...
Qu Tong-hui, Zhou Jia-le, Jia Yi-fei
doaj +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Molecular Oncology, EarlyView.Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source
南方能源建设[Objective] Hydrogen-based energy is a secondary energy source produced by the conversion of hydrogen as the major medium, which is of great significance for promoting the low-carbon transformation of the energy system and achieving the goal of carbon ...
Zhibin LUO +3 more
doaj +1 more source
Molecular Oncology, EarlyView.Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source